Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-25-211320
Filing Date
2025-09-22
Accepted
2025-09-22 16:12:15
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-1 mbx-20250922.htm S-1 1141234
2 EX-1.1 mbx-ex1_1.htm EX-1.1 356919
3 EX-5.1 mbx-ex5_1.htm EX-5.1 13927
4 EX-23.1 mbx-ex23_1.htm EX-23.1 3160
5 EX-FILING FEES mbx_exfilingfees.htm   iXBRL EX-FILING FEES 36584
6 GRAPHIC img84162877_0.jpg GRAPHIC 37211
7 GRAPHIC img102636436_0.jpg GRAPHIC 31217
8 GRAPHIC img102636436_1.jpg GRAPHIC 162458
9 GRAPHIC img102636436_2.jpg GRAPHIC 31217
  Complete submission text file 0001193125-25-211320.txt   2042530

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT mbx_exfilingfees_htm.xml XML 8385
Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-290447 | Film No.: 251330153
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)